Publication

The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaques

Downloadable Content

Persistent URL
Last modified
  • 05/22/2025
Type of Material
Authors
    Mireille Laforge, Université Paris DescartesRicardo Silvestre, Université Paris DescartesVasco Rodrigues, Université Paris DescartesJulie Garibal, Université Paris DescartesLaure Campillo-Gimenez, Université Paris DescartesShahul Mouhamad, Université Paris DescartesValérie Monceaux, Institut PasteurMarie-Christine Cumont, Institut PasteurHenintsoa Rabezanahary, Université LavalAlain Pruvost, Laboratoire d’Etude du Métabolisme des MédicamentsAnabela Cordeiro-da-Silva, Universidade do PortoBruno Hurtrel, Institut PasteurGuido Silvestri, Emory UniversityAnna Senik, Université Paris DescartesJérôme Estaquier, Université Paris Descartes
Language
  • English
Date
  • 2018-04-01
Publisher
  • American Society for Clinical Investigation
Publication Version
Copyright Statement
  • © 2018 American Society for Clinical Investigation. All rights reserved.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0021-9738
Volume
  • 128
Issue
  • 4
Start Page
  • 1627
End Page
  • 1640
Grant/Funding Information
  • JE thanks the Canada Research Chair program for financial assistance.
  • This study was supported by research funding from ANRS and CIHR (MOP-133476) to JE.
  • RS thanks Fundação para a Ciência e a Tecnologia (FCT) for Investigator FCT Grant IF/0002 1/2014.
  • VR is supported by a fellowship from FCT (code SFRH/BD/64064/2009).
  • ML and JG were supported by fellowships from ANRS.
Supplemental Material (URL)
Abstract
  • Apoptosis has been proposed as a key mechanism responsible for CD4+ T cell depletion and immune dysfunction during HIV infection. We demonstrated that Q-VD-OPH, a caspase inhibitor, inhibits spontaneous and activation-induced death of T cells from SIV-infected rhesus macaques (RMs). When administered during the acute phase of infection, Q-VD-OPH was associated with (a) reduced levels of T cell death, (b) preservation of CD4+/CD8+ T cell ratio in lymphoid organs and in the gut, (c) maintenance of memory CD4+ T cells, and (d) increased specific CD4+ T cell response associated with the expression of cytotoxic molecules. Although therapy was limited to the acute phase of infection, Q-VD-OPH-treated RMs showed lower levels of both viral load and cell-associated SIV DNA as compared with control SIV-infected RMs throughout the chronic phase of infection, and prevented the development of AIDS. Overall, our data demonstrate that Q-VD-OPH injection in SIV-infected RMs may represent an adjunctive therapeutic agent to control HIV infection and delaying disease progression to AIDS.
Author Notes
  • Address correspondence to: Jérôme Estaquier, Centre de Recherche du CHU de Québec, 2 705, Boul. Laurier, Quebec City, Quebec G1V 4G2, Canada. Phone: 418.656.4141; Email: estaquier@yahoo.fr.
Keywords
Research Categories
  • Biology, Molecular
  • Biology, Microbiology

Tools

Relations

In Collection:

Items